Yantai Dongcheng Pharmaceutical Group Co., Ltd., commonly referred to as Dongcheng Pharmaceutical, is a leading player in the pharmaceutical industry, headquartered in Yantai, China. Established in 1995, the company has made significant strides in the development and production of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong presence in both domestic and international markets, Dongcheng Pharmaceutical is renowned for its commitment to quality and innovation. The company’s core offerings, which include anti-infectives and cardiovascular medications, are distinguished by their adherence to stringent regulatory standards and advanced manufacturing processes. Recognised for its robust market position, Dongcheng Pharmaceutical continues to achieve notable milestones, solidifying its reputation as a trusted name in healthcare solutions.
How does Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s score of 11 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Yantai Dongcheng Pharmaceutical Group Co., Ltd., headquartered in China, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of information suggests that Yantai Dongcheng Pharmaceutical Group may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed their initiatives. As the pharmaceutical industry increasingly focuses on sustainability and reducing carbon footprints, it will be essential for Yantai Dongcheng to establish clear climate commitments and reduction targets to align with global efforts in combating climate change.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.